Drug-eluting stents (DES) are used to treat heart artery blockages. Under the updated price structure notified by the state ...

Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.

The USTR has raised alarms over India's price caps on coronary stents and high customs duties on drug formulations, arguing ...

Due to advancements spurred by AI/ML, the impact of digital health technology will grow. Data from the Department for Promotion of Industry and Internal Trade show that FDI in the medicines and ...

Currently, all drug-eluting stents (DES), used to treat blocked heart arteries, are priced at Rs 35,000. The Indian Express ...

The order says stents approved by the United States Food and Drug Adminis-tration will be priced at Rs 25,000 per stent, and ...

Investigators seeking to compare real-world outcomes with drug-eluting stents (DES) in symptomatic femoropopliteal lesions have s ...

The Gujarat government has stated that the move aims to ensure "cost-effectiveness while ensuring high-quality patient care" ...

NPPA allows stent manufacturers to revise prices by 1.74% based on WPI, ensuring compliance with DPCO regulations.

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Coronary Stents Market ...

According to the new price notified by the drug price regulator, the ceiling price of Bare Mental Stents is Rs 10692.69 & ...